A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype

Thrombosis Research

Volumn 92, Issue 3, 1998, Pages 141-148

  Gemmati, Donato ^a   Serino, Maria L ^a   Scapoli, Gian L ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

APC resistance; Factor V Leiden; Global assay; ProC ; Protein C activity; Protein S activity; Screening test

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; SNAKE VENOM;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULATION; ARTICLE; DNA DETERMINATION; ENZYME ASSAY; ENZYME SPECIFICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; SCREENING; THROMBOPHILIA; THROMBOSIS;

EID: 0032213122     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00120-0     Document Type: Article

References (24)

1. Dahlbäck B. The protein C anticoagulant system. Inherited defects as basis for venous thrombosis Thromb Res. 77:1995;1-43.
2. Griffin J.H., Evatt B., Wideman C., Fernandez J.A. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood. 82:1993;1989-1993.
3. Malm J., Laurell M., Dahlbäck B. Changes in the plasma levels of vitamin-K dependent protein C and S and of C4b-binding protein during pregnancy, and oral contraception. Br J Haematol. 68:1988;437-488.
4. Olivieri O., Friso S., Manzato F., Guella A., Bernardi F., Lunghi B., Girelli D., Azzini M., Brocco G., Russo C., Corrocher R. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol. 91:1995;465-470.
5. Amer L., Kisiel W., Searles S.P., Williams R.C. Jr. Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res. 57:1990;247-258.
6. Kraus M., Noah M., Fickenscher K. The PCAT - A simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res. 79:1995;217-222.
7. Robert A., Eschwege V., Hameg H., Drouet L., Aillaud M.F. Anticoagulant response to Agkistrodon Contortix Venom (ACV test). A new global test to screen for defects in the anticoagulant protein C pathway Thromb Haemost. 75:1996;562-566.
8. Preda L., Simioni P., Legnani C., Palareti G., Poggio M., Rossi E., Girolami A. A new global test for the evaluation of the protein-C system. Blood Coag Fibrinolysis. 7:1996;465-469.
9. Dati F., Hafner G., Erbes H., Prellwitz W., Kraus M., Niemann F., Noah M., Wagner C. ProC®Global. The first functional screening assay for the complete protein C pathway Clin Chem. 43:1997;1719-1723.
10. Francis R.B. Jr., Patch M.J. A functional assay for protein C in human plasma. Thromb Res. 32:1983;605-613.
11. Preda L., Tripodi A., Valsecchi C., Lombardi A., Finotto E., Mannucci P.M. A prothrombin time-based functional assay of protein S. Thromb Res. 60:1990;19-32.
12. Dahlbäck B., Carlsson M., Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated PC Proc Natl Acad Sci USA. 90:1993;1004-1008.
13. Nathan Ping H. IV, Pradham M.M. Protein C functional assay using snake venom activator. Thromb Res. 47:1987;85-91.
14. Varadi K., Moritz B., Lang H., Bauer K., Preston E., Peake I., Rivard J.E., Keil B., Schwartz H.P. A chromogenic assay for activated protein C resistance. Br J Haematol. 90:1995;884-891.
15. Wiesel M.-L., Charmantier J.-L., Freyssinet J.-M., Grunebaum L., Schuhler S., Cazenave J.-P. Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis. Thromb Res. 58:1990;461-468.
16. Solano C., Hogg A.L., Saal R.J., Scott D.C., Coberoft R.G. The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance. Blood Coag Fibrinolysis. 8:1997;268-273.
17. Jorquera J.I., Montoro J.M., Fernandez M.A., Aznar J.A., Aznar J. Modified test for activated protein C resistance. Lancet. 344:1995;1162-1163.
18. Wolf M., Boyer-Neumann C., Martinoli J.L., Leroy-Matheron C., Meyer D., Larrieu M.J. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost. 62:1989;1144-1145.
19. Gemmati D., Serino M.L., Verzola I., Mari R., Moratelli S., Ballerini G. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families. A correct diagnosis Blood Coag Fibrinolysis. 8:1997;118-123.
20. Gemmati D., Serino M.L., Mari R., Verzola I., Moratelli S., Ballerini G. Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix Venom (ACV test) in a family with FV-R506Q substitution. Clin Appl Thromb Hem. 3:1997;168-173.
21. Faioni E.M., Franchi F., Asti D., Sacchi E., Bernardi F., Mannucci P.M. Resistance to activated protein C in nine thrombophilic families. Interference in a protein S functional assay Thromb Haemost. 70:1993;1067-1071.
22. Ortega I.S., Pinto C.R., Urgelles M.F., Luengo J.R. Influence of protein C resistance (APC-R) on the determination of proteins C and S by functional clotting assays. Blood Coag Fibrinolysis. 6:1995;683.
23. Takahashi H., Tatewaki W., Wada K., Shibata A. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy. Clin Chim Acta. 182:1989;195-208.
24. Denson K.W.E., Haddon M.E., Reed S.V., Davidson S., Littlewood T.J. A more discriminating test for APC resistance and a possible screening test to include protein C and protein S. Thromb Res. 81:1996;151-156.